CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue
Total revenue	$ 165,105	$ 95,758
Operating expenses
Cost of services	144,204	83,432
General and administrative expenses	11,834	10,264
Depreciation and amortization	4,702	4,418
Provision for doubtful accounts	0	951
Total expenses	160,740	99,065
Income (loss) from operations	4,365	(3,307)
Other income (expense)
Income (loss) from equity method investments	2,054	(850)
Interest expense	(2,868)	(211)
Interest income	929	323
Other income	102	187
Total other income (expense), net	217	(551)
Income (loss) before provision for (benefit from) income taxes	4,582	(3,858)
Provision for (benefit from) income taxes	1,595	(1,408)
Net income (loss)	2,987	(2,450)
Net loss attributable to noncontrolling interests	(1,065)	(2,590)
Net income attributable to Apollo Medical Holdings, Inc.	$ 4,052	$ 140
Earnings per share – basic (in dollars per share)	$ 0.11	$ 0.00
Earnings per share – diluted (in dollars per share)	$ 0.11	$ 0.00
Weighted average shares of common stock outstanding – basic (in shares)	36,010,268	34,496,622
Weighted average shares of common stock outstanding – diluted (in shares)	37,439,099	38,074,174
Capitation, net
Revenue
Total revenue	$ 140,421	$ 71,517
Risk pool settlements and incentives
Revenue
Total revenue	11,236	10,094
Management fee income
Revenue
Total revenue	8,815	8,997
Fee-for-service, net
Revenue
Total revenue	3,427	4,081
Other income
Revenue
Total revenue	$ 1,206	$ 1,069